Literature DB >> 29186561

Identification of 5-Fluoro ADB in Human Whole Blood in Four Death Cases.

Kiyotaka Usui1, Yuji Fujita2, Yoshito Kamijo3, Tetsuo Kokaji4, Masato Funayama1.   

Abstract

Four deaths that seemed to have been caused by a designer drug occurred within a 3-week period in Sendai, Japan. In each case, the decedent possessed the same sachet, labeled "Heart Shot BLACK", which contained a dried plant material with an aromatic scent. It was revealed in our analysis that the product contained a synthetic cannabinoid receptor agonist, 5-fluoro ADB (methyl 2-[1-(5-fluoropentyl)-1H-indazole-3-carboxamide]-3,3-dimethylbutanoate, also known as 5-fluoro MDMB-PINACA), which is now classified as a restricted designer drug in Japan after it caused several casualties. For standard samples, the detection of 5-fluoro ADB in whole blood in the calibration range (0.04-4 ng/mL) was successful with recoveries of 94.6-98.1%, limits of detection of 6 pg/mL, and limits of quantification of 40 pg/mL. The intraday and interday precisions were 0.9-4.8% and 1.1-6.6%, respectively. The bias was -1.1 to 2.9%. We were able to confirm that 5-fluoro ADB was present in the blood of all four decedents at a concentration of 0.11-1.92 ng/mL. From the autopsy, toxicological findings, and circumstances surrounding the cases, it was considered that inhalation of 5-fluoro ADB could have contributed to the deaths. However, the extent to which 5-fluoro ADB contributed to the deaths remains unclear due to the current lack of toxicological information on the compound. In future research, the toxicity of 5-fluoro ADB in humans and the mechanism underlying this effect need to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29186561     DOI: 10.1093/jat/bkx088

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  6 in total

1.  Synthetic Cannabinoid Hydroxypentyl Metabolites Retain Efficacy at Human Cannabinoid Receptors.

Authors:  Thomas F Gamage; Charlotte E Farquhar; Ryan J McKinnie; Richard C Kevin; Iain S McGregor; Mark L Trudell; Jenny L Wiley; Brian F Thomas
Journal:  J Pharmacol Exp Ther       Date:  2018-12-14       Impact factor: 4.030

2.  Involuntary 5F-ADB-related intoxication following e-cigarette use.

Authors:  Sophie Salle; Christelle Sevestre; Camille Richeval; Florian Hakim; Delphine Allorge; Jean-Michel Gaulier
Journal:  Int J Legal Med       Date:  2021-03-25       Impact factor: 2.686

3.  Analytical Methodologies for the Characterization and Analysis of the Parent Compound and Phase I Metabolites of 4F-MDMB-BICA in Human Microsome, Urine, and Blood Samples.

Authors:  Tímea Körmöczi; Éva Sija; László Institóris; Éva M Kereszty; István Ilisz; Róbert Berkecz
Journal:  J Anal Toxicol       Date:  2021-01-06       Impact factor: 3.367

4.  Post-Mortem Toxicology: A Systematic Review of Death Cases Involving Synthetic Cannabinoid Receptor Agonists.

Authors:  Arianna Giorgetti; Francesco Paolo Busardò; Roberta Tittarelli; Volker Auwärter; Raffaele Giorgetti
Journal:  Front Psychiatry       Date:  2020-05-25       Impact factor: 4.157

5.  Accidental Ingestion of a Novel Psychoactive Substance: A Case Report.

Authors:  Abhay Kant; Rupeng Mong; Hock Heng Tan
Journal:  Cureus       Date:  2020-10-26

Review 6.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.